On Monday, Quarterhill announced that because of strong results from its Wi-LAN subsidiary, it expects revenue for the third quarter will come in at between $72.5-million and $82.5-million, and that EBITDA would be between $50.0-million and $56.0-million.
“We are very pleased to have such a substantial contribution from Wi-LAN this quarter,” said interim CEO Shaun McEwan. “As we have said in the past, financial results in this segment of our business can be variable from quarter to quarter and this is a prime example of the upside potential of this variability. Our expected results for the third quarter will provide a significant boost to our cash position, which will assist in the continued growth of Quarterhill.”
Kim says despite looming changes there is deep value in Quarterhill.
“On the back of a strong license renewal, which was in part motivated to get a jump on pending accounting changes commencing in the New Year, QTRH updated its thirdquarter outlook with record guidance,” the analyst notes. “This announcement has pushed the valuation of the shares back into buy territory, in our opinion, trading at 1.9x 2017e EV/EBITDA and 3.6x P/E. In this note, we provide a base-case and high-case analysis, which suggests there is meaningful unlocked value in these shares. We caution investors, however, the ride beginning in 2018 will get bumpier.”
In a research update to clients today, Kim upgraded Quarterhill from “Hold” to “Buy” and raised his one-year price target on the stock from $2.00 to $2.75.
Kim thinks Quarterhill will generate EBITDA of $60.1-million on revenue of $132.7-million in fiscal 2017. He expects those numbers will fall to EBITDA of $21.4-million on a topline of $109.1-million the following year.
It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]
Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]
Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]
It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]
Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]
Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]